Lilly Hopes To Differentiate Omvoh In Crohn’s With Histologic Data

 
• By Joseph Haas
  
This is a picture of the Lilly building in San Diego
Lilly is positioning Omvoh against other IL-23 antagonists in Crohn's disease (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapy Areas